Across 2,339 adults with obesity or overweight, all three doses of retatrutide met the primary and key secondary endpoints at 80 weeks
Emerging studies are exploring the potential of GLP-1-based therapies in diverse populations and comorbidities, such as patients with type 2 diabetes or cardiovascular diseases
These mechanisms are scientifically plausible, but they are not yet established well enough to say that GLP-1 drugs directly age the face independent of weight loss
There are some people who are under-responders, there are some people who are over-responders, and theres some that respond as expected to the medication, Narang said
Do not take large amounts of opioids, including opioid-containing medicines, such as heroin or prescription pain pills, to try to overcome the opioid-blocking effects of naltrexone
"Women deserve to have a clinical trial specifically looking at [GLP-1 and] breast cancer risk, and a clinical trial is the only way to ensure equity in who gets the drugs." The good news is that the INSPIRE trial could begin in as little as six months, once it has sufficient funding
